|
NDRA ENDRA Life Sciences Inc 1681682 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$159,944.00 |
| Balance Sheet |
|
Current Assets
|
$5,587,010.00 |
|
Assets
|
$7,942,205.00 |
|
Current Liabilities
|
$786,578.00 |
|
Liabilities
|
$1,632,514.00 |
|
Equity
|
$6,309,691.00 |
|
Shares Out
|
1499838.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,047,210.00 |
|
Investing Cash Flow
|
$2,667,105.00 |
| Market Analysis |
Market Cap
|
$6,884,256.42 |
|
Price
|
$4.59 |
|
BVPS
|
4.21 |
|
PB
|
1.09 |
|
EPS
|
0.12 |
|
FCF
|
$-2,065,880.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:01 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:51 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NDRA documents filed with the SEC.
NDRA Filings
Clear
